Drug and Chemical Toxicology

Top Research Topics at Drug and Chemical Toxicology?

Pharmacology, Toxicity, Internal medicine, Endocrinology and Biochemistry are among the topics commonly tackled in Drug and Chemical Toxicology. The concepts on Pharmacology presented in Drug and Chemical Toxicology can also apply to other research fields, including Oxidative stress, Antioxidant, Glutathione, Genotoxicity and In vivo. Oxidative stress studies presented include Lipid peroxidation and Superoxide dismutase.

The studies on Genotoxicity discussed can also contribute to research in the domains of DNA damage, Comet assay, Micronucleus, Micronucleus test and Molecular biology. It focuses on In vivo as well as the interrelated topic of In vitro. The work on Toxicity tackled in the journal brings together disciplines like Oral administration, Inhalation, Toxicology, Developmental toxicity and Physiology.

Kidney is a major topic of Internal medicine research presented in the journal. The close relationship between Gestation and Fetus is one of the points of interest dissected in Endocrinology research. Biochemistry research is the primary subject tackled in it with a focus on Metabolism.

• Pharmacology (31.76%)
• Toxicity (28.78%)
• Internal medicine (25.51%)

What are the most cited papers published in the journal?

• Serum enzymes as indicators of chemically induced liver damage. (310 citations)
• Thymoquinone is a potent superoxide anion scavenger (304 citations)
• NMR-BASED METABOLOMICS (245 citations)

Research areas of the most cited articles at Drug and Chemical Toxicology:

The most cited papers are mainly concerned with subjects like Toxicity, Pharmacology, Internal medicine, Endocrinology and Biochemistry. The studies on Toxicity discussed at the most cited articles can also contribute to research in the domains of In vitro, Surgery, Toxicology, Developmental toxicity and Physiology. The journal papers explore issues in Endocrinology which can be linked to other research areas like Pregnancy and Gestation.

What topics the last edition of the journal is best known for?

• Internal medicine
• Enzyme
• Biochemistry

The previous edition focused in particular on these issues:

The journal focuses largely on the fields of Pharmacology, Oxidative stress, Toxicity, Internal medicine and Endocrinology. Pharmacology is the main point of discussion in the journal but it also connects with fields such as

• Apoptosis that connect with fields like Cancer,
• Nephrotoxicity and related Gentamicin.. The studies in Oxidative stress featured incorporate elements of Glutathione and Antioxidant.

The journal addresses concerns in the field of Toxicity by exploring it in line with topics in Cytotoxicity which intersect with Cancer research subjects. The majority of Endocrinology studies are focused on the issues of Testosterone. The journal explores research in Diabetes mellitus and overlapping concepts in Traditional medicine to expand the discourse in Acute toxicity.

The most cited articles from the last journal are:

• Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies (32 citations)
• Nanoformulations and their mode of action in insects: a review of biological interactions. (18 citations)
• Cardiotoxicity evaluation and comparison of diterpene alkaloids on zebrafish (14 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Drug and Chemical Toxicology (based on the number of publications) are:

• Gerald L. Kennedy (45 papers) absent at the last edition,
• Kimber L. White (19 papers) absent at the last edition,
• Larrel W. Harris (17 papers) absent at the last edition,
• Leila Chekir-Ghedira (15 papers) absent at the last edition,
• Kamel Ghedira (15 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Drug and Chemical Toxicology (based on the number of publications) are:

• DuPont (65 papers) absent at the last edition,
• United States Department of the Army (56 papers) published 2 papers at the last edition,
• Mashhad University of Medical Sciences (47 papers) published 7 papers at the last edition the same number as at the previous edition,
• United States Environmental Protection Agency (33 papers) absent at the last edition,
• Panjab University, Chandigarh (21 papers) published 1 paper at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.28% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.08% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.51% of all publications and 65.54% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.